Predictive factors for success of chronic atrial fibrillation after DC cardioversion
분야
의약학 > 내과학
저자
( Han Jun Bae ) , ( Hong Won Shin ) , ( Ho Myoung Lee ) , ( Hyun Ok Cho ) , ( Ji Hyun Son ) , ( Yun Kyeong Cho ) , ( Hyoung Seob Park ) , ( Hyuck Jun Yoon ) , ( Hyung Seop Kim ) , ( Chang Wook Nam ) , ( Seung Ho Hur ) , ( Yun Nyun Kim ) , ( Kwon Bae Kim )
발행기관
대한내과학회
간행물정보
대한내과학회 추계학술발표논문집 2011년, 제2011권 제1호, 162(총1페이지)
파일형식
42846475.pdf [무료 PDF 뷰어 다운로드]
  • ※ 본 자료는 참고용 논문으로 수정 및 텍스트 복사가 되지 않습니다.
  • 구매가격
    1,000원
    적립금
    30원 (구매자료 3% 적립)
    이메일 발송  스크랩 하기
    자료 다운로드  네이버 로그인
    영문초록
    Background: Rate control and rhythm control was recommended strategy for patients with atrial fibrillation(AF). Cardioversion, pharmacologic agent and catheter ablation was done to achieve sinus rhythm. Cardioversion and pharmacological conversion are appropriate option. We evaluate predictive factor for success of atrial fibrillation after DC cardioversion Methods: 137 patients with chronic AF to undergo cardioversion reveived serial monophasic (100, 200, 300 up to 360J)shock or serial biphasic(100, 150, up to 200J) shock. Results: 105 of 137 patients was restoration to sinus rhythm. Restoration group used more beta-blocker (29.8 vs 6.3%) and more amiodarone(32.7 vs 12.5). And enlarged left atrial dimension(4.70 vs 4.48 mm), more elderly(58.7 vs 53.9), higher body mass index(BMI, 25.3 vs 23.8) was associated to sinus conversion. Age(p=0.01), BMI (p=0.03), beta-blocker(p=0.009) were independently associated with outcome by multivariate analysis. Conclusion: DC conversion to sinus rhythm for patients with AF is associated with more elderly, higher BMI and used beta-blocker patients.
    사업자등록번호 220-87-87785 대표.신현웅 주소.서울시 서초구 방배로10길 18, 402호 대표전화.070-8809-9397
    개인정보책임자.박정아 통신판매업신고번호 제2017-서울서초-1765호 이메일 help@reportshop.co.kr
    copyright (c) 2009 happynlife. steel All reserved.